| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $153.1M | — | +15.8% |
| Cost of Revenue | $85.9M | — | +9.6% |
| Gross Profit | $67.1M | — | +25.9% |
| R&D Expense | $11.7M | — | +20.6% |
| SG&A Expense | $39.4M | — | +5.9% |
| Operating Income | $15.9M | — | +297.5% |
| Pre-tax Income | $11.0M | — | +1275.0% |
| Income Tax | -$300K | — | -125.0% |
| Net Income | $9.7M | — | +585.0% |
| EPS (Basic) | $0.11 | — | +650.0% |
| EPS (Diluted) | $0.11 | — | +650.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $41.0M | -24.4% | -59.8% |
| Accounts Receivable | $109.2M | +6.2% | +2.2% |
| Inventory | $136.2M | +9.3% | +13.5% |
| Current Assets | $297.4M | +2.1% | -12.0% |
| Total Assets | $1.05B | +0.3% | -3.9% |
| Current Liabilities | $90.9M | -14.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$700K | — | -153.8% |
| Capital Expenditures | $10.8M | — | +170.0% |
| Investing Cash Flow | -$10.8M | — | -208.6% |
| Financing Cash Flow | -$1.8M | — | +93.1% |
| Free Cash Flow | -$11.5M | — | -325.9% |
| -45.8% |
| Long-term Debt | $131.0M | +14.9% | -30.6% |
| Stockholders' Equity | $780.2M | +0.6% | +3.2% |